Clinical trial
Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis…
NCT00002557 · National Cancer Institute (NCI), NIH · Unknown status
Key facts
| NCT number | NCT00002557 |
|---|---|
| Title | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides |
| Official title | PROTOCOL FOR THE MANAGEMENT OF MYCOSIS FUNGOIDES AND THE SEZARY SYNDROME |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | CHOP regimen, doxorubicin hydrochloride, etoposide, leucovorin calcium, methotrexate |
| Enrollment | 3 |
| Start date | Jun 1, 1993 |
| First posted | Jul 19, 2004 |
| Last update posted | Dec 18, 2013 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: